Publicaciones en colaboración con investigadores/as de University Medical Center Utrecht (107)

2023

  1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

    The Lancet, Vol. 401, Núm. 10374, pp. 347-356

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. ALL-tRNAseq enables robust tRNA profiling in tissue samples

    Genes & development, Vol. 37, Núm. 5-6, pp. 243-257

  4. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  5. GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors

    American Journal of Psychiatry

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

  2. Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options

    Updates in Surgery, Vol. 74, Núm. 1, pp. 325-335

  3. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  4. Natural History of MYH7-Related Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461

  5. The Effect of Body Fat Distribution on Systemic Sclerosis

    Journal of Clinical Medicine, Vol. 11, Núm. 20

2021

  1. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (Nature Communications, (2021), 12, 1, (2349), 10.1038/s41467-021-22446-z)

    Nature Communications

  2. Complications after medullary thyroid carcinoma surgery: Multicentre study of the SQRTPA and EUROCRINE®databases

    British Journal of Surgery, Vol. 108, Núm. 6, pp. 691-701

  3. Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 8, pp. 1040-1047

  4. Efficacy of color lenses in abolishing photosensitivity: Beyond the one-type-fits-all approach?

    Epilepsy and Behavior, Vol. 124

  5. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    Nature Communications, Vol. 12, Núm. 1

  6. Genomic Risk Score impact on susceptibility to systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 1, pp. 118-127

  7. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  8. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

    Nature Communications, Vol. 12, Núm. 1

  9. Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy

    European Journal of Heart Failure, Vol. 23, Núm. 8, pp. 1276-1286

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1